Prince Edward Island resident and JDRF advocate Brooks Roche is getting vocal about #AccessForAll.
JDRF advocate and Prime Minister’s Youth Council member demands Access for All in P.E.I.
Back to School and Hypoglycemia
Back to school includes a lot more than just a backpack, notebooks, and a pencil case. Getting back into the school routine requires a lot of preparation and planning for kids who live with type 1 diabetes (T1D)
Your participation in the 2020 Ride will help people like my wife Audrey
I want to tell you a little bit about my resilient wife, Audrey.
Flash glucose monitoring now covered for adults in the Yukon, but coverage for continuous glucose monitoring ends
The Yukon government has made the decision to fully fund flash glucose monitors (Flash GMs) for those 18 years of age and older with type 1 diabetes (T1D) starting on October 1st.
We are asking the government to renew crucial funds for T1D research
As 2021 draws near, we move closer to an important milestone that changed and aided the type 1 diabetes (T1D) community in an enormous way – the 100th year of insulin.
More choices for our T1D community: New Pumps Approved in BC
There’s good news for pumpers in BC! BC Pharmacare has added YpsoPump by YpsoMed to its Tier 1 list of approved insulin pumps. BC residents with type 1 diabetes of all ages can now choose between the Omnipod by Insulet or the YpsoPump under the province’s pump program.
Access For All Goes West
JDRF’s attention has been focused on Canada’s west coast increasingly as the BC government inches closer to a decision on whether or not to cover continuous glucose monitoring (CGM) and flash glucose monitoring (FGM) systems. BC Pharmacare commissioned a health technology assessment on these technologies more than a year ago but the results have yet to be released.
London, UK sees localized increase in pediatric T1D diagnoses – but experts say too early to blame COVID-19
A recent increase in type 1 diabetes (T1D) diagnoses in children under 18 in some hospitals in north-west London, UK, has triggered news stories that COVID-19 could cause the disease in children. But experts have stressed that the locally reported increase in diagnoses is not yet clearly linked to the pandemic.
Type 1 diabetes and COVID-19: Going back to school
As students across Canada get ready to head back to school—some after nearly 6 months of being away—parents have many questions. The first is usually, “Is it safe to send my child back to school during this pandemic?”
Here are some things to consider when making a decision about sending your child with type 1 diabetes (T1D) back to school.
Landmark trial of T1D-related kidney disease misses primary outcome, but provides valuable lessons
Kidney disease remains one of the leading complications of diabetes, including the need for dialysis or kidney transplant. This led to the Preventing Early Renal Loss in Diabetes (PERL) trial, a joint initiative between investigators across North America and Denmark.
Making the best of the COVID-19 situation
With visits to healthcare professionals (HCPs) now mostly virtual, tele-health and Zoom meetings now the norm, there comes a heavier reliance on self-monitoring.
To our community and our partners: Thank you
We are incredibly grateful to our partners, and the entire T1D community for their commitment and support as we work together to move type 1 diabetes research forward faster than ever.
